asciminib,imatinib,nilotinib
inhibikase
['cml', 'imatinib', 'asciminib']
#ash22 asc4more trial presented by imatinib in combination with asciminib. #cml early results showing comparable toxicity and deeper response in asciminib arm. 
Assistant Professor @MayoCancerCare @MayoClinic Alumni @MDAndersonNews. Interest in Acute Leukemia and Chronic myeloid disorders. Views are my own